INFINITY PHARMACEUTICALS INC's ticker is INFI and the CUSIP is 45665G303. A total of 119 filers reported holding INFINITY PHARMACEUTICALS INC in Q1 2016. The put-call ratio across all filers is 0.63 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $122,000 | +17.3% | 77,900 | 0.0% | 0.00% | – |
| Q2 2016 | $104,000 | -75.4% | 77,900 | -6.1% | 0.00% | -100.0% |
| Q1 2016 | $423,000 | -20.8% | 83,000 | +22.1% | 0.00% | 0.0% |
| Q4 2015 | $534,000 | -7.1% | 68,000 | 0.0% | 0.00% | 0.0% |
| Q3 2015 | $575,000 | -12.1% | 68,000 | +13.9% | 0.00% | -50.0% |
| Q2 2015 | $654,000 | -12.1% | 59,700 | +12.2% | 0.00% | 0.0% |
| Q1 2015 | $744,000 | -17.2% | 53,200 | 0.0% | 0.00% | -33.3% |
| Q4 2014 | $899,000 | +25.9% | 53,200 | 0.0% | 0.00% | 0.0% |
| Q3 2014 | $714,000 | +5.3% | 53,200 | 0.0% | 0.00% | 0.0% |
| Q2 2014 | $678,000 | +20.9% | 53,200 | +12.7% | 0.00% | +50.0% |
| Q1 2014 | $561,000 | +7.3% | 47,200 | +24.5% | 0.00% | 0.0% |
| Q4 2013 | $523,000 | +2.3% | 37,900 | +29.4% | 0.00% | 0.0% |
| Q3 2013 | $511,000 | +1.4% | 29,300 | -5.5% | 0.00% | 0.0% |
| Q2 2013 | $504,000 | – | 31,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 15,232,268 | $29,094,000 | 2.84% |
| EcoR1 Capital, LLC | 412,000 | $787,000 | 0.08% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 1,130,432 | $2,159,000 | 0.05% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 164,605 | $314,000 | 0.04% |
| Clear Harbor Asset Management, LLC | 95,630 | $183,000 | 0.03% |
| ALGERT GLOBAL LLC | 72,556 | $139,000 | 0.03% |
| 180 WEALTH ADVISORS, LLC | 30,000 | $57,000 | 0.03% |
| GSA CAPITAL PARTNERS LLP | 289,854 | $554,000 | 0.03% |
| PRELUDE CAPITAL MANAGEMENT, LLC | 85,412 | $163,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 459,000 | $877,000 | 0.01% |